John P. Butler - 01 Mar 2023 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Signature
/s/ Carolyn Rucci, attorney-in-fact for John P. Butler
Issuer symbol
AKBA
Transactions as of
01 Mar 2023
Net transactions value
-$80,614
Form type
4
Filing time
03 Mar 2023, 07:01:34 UTC
Previous filing
01 Mar 2023
Next filing
15 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale $33,572 -38,259 -2.3% $0.8775 1,622,481 01 Mar 2023 Direct F1
transaction AKBA Common Stock Sale $41,452 -47,239 -2.9% $0.8775 1,575,242 01 Mar 2023 Direct F2
transaction AKBA Common Stock Sale $5,590 -6,370 -0.4% $0.8775 1,568,872 01 Mar 2023 Direct F3
holding AKBA Common Stock 100,000 01 Mar 2023 Held By John Butler GRAT November 2019
holding AKBA Common Stock 59,928 01 Mar 2023 Held by John Butler 2019 GRAT
holding AKBA Common Stock 100,000 01 Mar 2023 Held By Dorothy Butler GRAT November 2019
holding AKBA Common Stock 59,928 01 Mar 2023 Held by Dorothy Butler 2019 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.
F2 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.
F3 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.